Evotec

Pharmaceuticals
EVT.DE
€ 25 2.6
Share price
$ 4.6 bn
Market Cap
$ 4 bn
Enterprise Value

Carbon footprint

0.05 Ton
GHG emissions per $ 1 mln investment
0x the weighted average for S&P 500
FY2020
How is this calculated?
-73%
YOY change in GHG emissions
Stronger than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Evotec's GHG emissions (market-based) (Kt of CO2e)
Evotec's Carbon intensity (Tons per 1 USDm)

Evotec's carbon footprint

Evotec reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 0.21 Kt (-0.55 /-72.6% y-o-y). Also positively, carbon intensity decreased to 0.4 t (-1.1 /-73.3% y-o-y).

No public disclosure of Scope 3 emissions has been found for Evotec at the moment.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Company environmental metrics

Show more...